Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses

8d ago

SCLX

PremiumPress Releases

Scilex Holding Company Announces Launching of Co-Pay Programs for Both ZTlido® and ELYXYB® for Commercially Insured Patients and the addition of ELYXYB® to a Multi-State Medicaid Pharmaceutical Purchasing Group to Its Purchasing Pool

15d ago

SCLX

PremiumPress Releases

Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Stock Previously Distributed by Sorrento to its Stockholders as a Dividend

28d ago

SCLX

PremiumCompany Announcements

Scilex Holding Ends Equity Purchase Deal with Yorkville

29d ago

SCLX

PremiumPress Releases

Scilex Holding Company Announces New Out-of-Pocket Costs for Commercially Insured Patients

1M ago

SCLX

PremiumPress Releases

Scilex Holding Company Announces Seeking Approval from the FDA for Modification of the Gloperba® Label to Provide Specific Dosing Guidance for Patients with Renal Impairment and Other Circumstances Where Dose Adjustment is Needed

1M ago

SCLX

PremiumPress Releases

Scilex Holding Company Announces a Settlement Agreement with Takeda Pharmaceuticals to Resolve the Paragraph IV Patent Infringement Lawsuit Relating to Scilex’s Filing of a sNDA with the FDA Seeking to Expand the Label for its FDA-Approved Liquid Colchicine Product, Gloperba®

1M ago

SCLX

More SCLX News >

SCLX News on the Web

2024-03-25

Scilex Holding Ends Equity Purchase Deal with Yorkville

TipRanks News

Neutral

2024-03-15

Scilex reaches settlement in Sorrento bankruptcy case

Investing.com

Neutral

2024-03-15

Scilex reaches settlement in Sorrento bankruptcy case

Investing.com

Neutral

2024-03-05

Scilex Holding Company Sets Launch Price of $595 per 150ml bottle of Gloperba®, its First and Only Liquid Oral Version of the Anti-Gout Medicine Colchicine Indicated for the Prophylaxis of Painful Gout Flares in Adults; Expected Plans to Launch in the First Half of 2024

Yahoo Finance

Neutral

2024-03-01

Healthcare Stocks Making Moves Friday: ADIL, BIVI, CRDF, LIFW, SCLX, DTIL, VANI, HUMA

Investors Observer

Neutral

2024-03-01

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

InvestorPlace

Neutral

2024-02-26

Scilex settles lawsuit with Virpax Pharmaceuticals

Investing.com

Bearish

2024-02-26

Scilex settles lawsuit with Virpax Pharmaceuticals

Investing.com

Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

Currently, no data available

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SCLX’s Media Buzz Sentiment?

Currently, no data Available

What is SCLX’s weekly average amount of articles?

Currently, no data Available

What is SCLX’s News Sentiment?

Currently, no data Available

Healthcare Stocks that are Trending in the News

ELVElevance Health

CGEMCullinan Management

MRNSMarinus

EWEdwards Lifesciences

INSPInspire Medical Systems

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing